Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) HKSE
18.07
-0.43(-2.32%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.09B |
| Enterprise Value | 3.04B |
| P/E Ratio | 33 |
| PEG Ratio | -0.48 |
| Price/Sales Ratio | 2.69 |
| Price/Book Ratio | 1.42 |
| Enterprise/Revenue | 1.9 |
| Enterprise/EBITDA | 13.58 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.08 |
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 2.45B |
| Revenue/Share | 10.76 |
| Gross Profit | 1.69B |
| EBITDA | 418.16M |
| Net Income | 244.51M |
| Diluted EPS | 1.08 |
Balance Sheet
| Total Cash | 2.4B |
| Total Cash/Share | 10.69 |
| Total Debt | 416.01M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 3.73 |
| Book Value Per Share | 24.83 |
Price History
| 52-Week Change | -30.77 |
| 52-Week High | 31.28 |
| 52-Week Low | 18 |
| Moving Average 50 Days | 21.67 |
| Moving Average 200 Days | 25.31 |
Statistics
| Average Volume | 168,835 |
| Shares Outstanding | 401.99M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 2.92 |
| Payout Ratio | 1.33 |
| Last Split Factor | 7:5 |
| Last Split Date | June 06, 2024 |
